| JSGZX | VSGIX | JSGZX / VSGIX | |
| Total Expense Ratio | 1.49 | 0.06 | 2,483% |
| Annual Report Gross Expense Ratio | 1.53 | 0.06 | 2,550% |
| Fund Existence | 17 years | 26 years | - |
| Gain YTD | 1.629 | 10.840 | 15% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.8B | 39.7B | 7% |
| Annual Yield % from dividends | 0.31 | 0.55 | 56% |
| Returns for 1 year | 0.00 | 8.53 | - |
| Returns for 3 years | 30.68 | 55.77 | 55% |
| Returns for 5 years | -32.55 | 14.92 | -218% |
| Returns for 10 years | 43.07 | 158.30 | 27% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JDITX | 16.70 | 0.02 | +0.12% |
| JHancock Disciplined Value Intl R4 | |||
| WAIGX | 14.80 | 0.01 | +0.07% |
| Wasatch International Growth Investor | |||
| MMNJX | 15.01 | 0.01 | +0.07% |
| MassMutual Small Cap Gr Eq Y | |||
| RYMRX | 20.87 | 0.01 | +0.05% |
| Guggenheim Multi-Hedge Strategies C | |||
| ETNHX | 51.47 | N/A | N/A |
| Eventide Healthcare & Life Sciences N | |||